MedTrace Logo

Effects of TUDCA on Endothelial Function in Type 2 DM

NCT03462940 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2021-03-24

No results posted yet for this study

Summary

The pilot study is designed to investigate the acute and chronic effects of the diet supplement tauroursodeoxycholic acid (TUDCA) on endothelial function in participants with type 2 diabetes mellitus.

Conditions

  • Diabetes Mellitus, Type 2
  • Insulin Response
  • Endothelial Dysfunction

Interventions

DIETARY_SUPPLEMENT

Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is an ambiphilic bile acid. It is the taurine conjugate form of ursodeoxycholic acid.

Sponsors & Collaborators

  • Boston University

    lead OTHER

Principal Investigators

  • Naomi Hamburg, MD · Boston University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-02
Primary Completion
2021-02-09
Completion
2021-02-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03462940 on ClinicalTrials.gov